Establishing the overall efficacy or safety of a drug requires a unified methodological approach and analysis of all clinical trials to be included. As an example, this paper presents the aggregated dose-response relationship of efficacy data and a last-value analysis of laboratory data across all s
✦ LIBER ✦
Hemodynamic profile of carvedilol
✍ Scribed by V. Hombach; M. Kochs; M. Höher; T. Eggeling; W. Haerer; S. Wieshammer; A. Schmidt
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 352 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Hemodynamic and metabolic effects of car
✍
Stienen, U. ;Meyer-Sabellek, W.
📂
Article
📅
1992
🏛
Springer-Verlag
🌐
English
⚖ 512 KB
Hemodynamic effects of one week of carve
✍
Han-Chieh Lin; Yi-Tsau Huang; Hung-Chi Wei; Ying-Ying Yang; Tzung-Yan Lee; Ying-
📂
Article
📅
2006
🏛
Springer Japan
🌐
English
⚖ 221 KB
Hemodynamic differences between carvedil
✍
R. R. Ruffolo; C. F. Sauermelch; R. N. Willette
📂
Article
📅
1990
🏛
Springer
🌐
English
⚖ 267 KB
Acute hemodynamic effects of carvedilol
✍
Wendt, T.
📂
Article
📅
1992
🏛
Springer-Verlag
🌐
English
⚖ 529 KB
In a randomized, double-blind study oral doses of 50 mg carvedilol (Dilatrend) were compared with 40 mg propranolol in 16 male patients with coronary heart disease, CHD [12 without significant stenoses following percutaneous transluminal coronary angioplasty (PTCA), 4 with multivessel disease]. Bicy
Effects of carvedilol on common carotid
✍
Y. Nagakawa; Y. Akedo; S. Kaku; H. Orimo
📂
Article
📅
1990
🏛
Springer
🌐
English
⚖ 537 KB
Carvedilol
📂
Article
📅
1999
🏛
Prelum Uitgevers
⚖ 58 KB